Biogen Alzheimer?s drug data falls flat, Lilly gets slight bump
 

Biogen Alzheimer?s drug data falls flat, Lilly gets slight bump
July 22 (Reuters) - Disappointing data for Biogen Inc's experimental Alzheimer's drug dragged shares in the company lower on Wednesday, while investors took a slightly more positive view of new findings for a treatment from Eli Lilly and Co.


http://rc.feedsportal.com/r/23456591...21/rc/1/rc.img

http://rc.feedsportal.com/r/23456591...21/rc/2/rc.img

http://rc.feedsportal.com/r/23456591...21/rc/3/rc.img

http://da.feedsportal.com/r/23456591...1/sc/21/a2.img
http://adchoice.feedsportal.com/r/23.../sc/21/ach.imghttp://pi.feedsportal.com/r/23456591.../sc/21/a2t.imghttp://pi2.feedsportal.com/r/2345659...sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1 http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Uo:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...Uo:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/f2Ga8yU-dLU